Staphylococcus aureus bacteremia in solid organ transplant recipients: Evidence for improved survival when compared with nontransplant patients

Transplantation

Volumn 93, Issue 10, 2012, Pages 1045-1050

  Malinis, Maricar F ^a   Mawhorter, Steven D ^a   Jain, Anil ^b   Shrestha, Nabin K ^a   Avery, Robin K ^a   Van Duin, David ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Explorys Inc   (United States)

Author keywords

Bacteremia; Endocarditis; Mortality; Pneumonia; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CEFAZOLIN; CLINDAMYCIN; CORTICOSTEROID; DAPTOMYCIN; LINEZOLID; METICILLIN; MYCOPHENOLIC ACID; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RAPAMYCIN; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL PNEUMONIA; BLOOD CULTURE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOLID ORGAN TRANSPLANTATION; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PNEUMONIA, STAPHYLOCOCCAL; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84861101052     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31824bf219     Document Type: Article

References (27)

1. Wagener MM, Yu VL. Bacteremia in transplant recipients: A prospective study of demographics, etiologic agents, risk factors, and outcomes. Am J Infect Control 1992; 20: 239.
2. Husain S, Chan KM, Palmer SM, et al. Bacteremia in lung transplant recipients in the current era. Am J Transplant 2006; 6: 3000.
3. Manuel O, Lien D, Weinkauf J, et al. Methicillin-resistant Staphylococcus aureus infection after lung transplantation: 5-year review of clinical and molecular epidemiology. J Heart Lung Transplant 2009; 28: 1231.
4. Palmer SM, Alexander BD, Sanders LL, et al. Significance of blood stream infection after lung transplantation: Analysis in 176 consecutive patients. Transplantation 2000; 69: 2360.
5. Haddad F, Deuse T, Pham M, et al. Changing trends in infectious disease in heart transplantation. J Heart Lung Transplant 2010; 29: 306.
6. Singh N, Paterson DL, Chang FY, et al. Methicillin-resistant Staphylococcus aureus: The other emerging resistant gram-positive coccus among liver transplant recipients. Clin Infect Dis 2000; 30: 322.
7. Silva M Jr, Marra AR, Pereira CA, et al. Bloodstream infection after kidney transplantation: Epidemiology, microbiology, associated risk factors, and outcome. Transplantation 2010; 90: 581.
8. Lambert ML, Suetens C, Savey A, et al. Clinical outcomes of healthcare- associated infections and antimicrobial resistance in patients admitted to European intensive-care units: A cohort study. Lancet Infect Dis 2011; 11: 30.
9. Noskin GA, Rubin RJ, Schentag JJ, et al. National trends in Staphylococcus aureus infection rates: Impact on economic burden and mortality over a 6-year period (1998Y2003). Clin Infect Dis 2007; 45: 1132.
10. Noskin GA, Rubin RJ, Schentag JJ, et al. The burden of Staphylococcus aureus infections on hospitals in the United States: An analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. Arch Intern Med 2005; 165: 1756.
11. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309.
12. Asgeirsson H, Gudlaugsson O, Kristinsson KG, et al. Staphylococcus aureus bacteraemia in Iceland, 1995Y2008: Changing incidence and mortality. Clin Microbiol Infect 2011; 17: 513.
13. Hafkin J, Blumberg E. Infections in lung transplantation: New insights. Curr Opin Organ Transplant 2009; 14: 483.
14. Lodise TP Jr, McKinnon PS, Rybak M. Prediction model to identify patients with Staphylococcus aureus bacteremia at risk for methicillin resistance. Infect Control Hosp Epidemiol 2003; 24: 655.
15. Pujol M, Pena C, Pallares R, et al. Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1994; 13: 96.
16. Rodriguez C, Munoz P, Rodriguez-Creixems M, et al. Bloodstream infections among heart transplant recipients. Transplantation 2006; 81: 384.
17. Torre-Cisneros J, Herrero C, Canas E, et al. High mortality related with Staphylococcus aureus bacteremia after liver transplantation. Eur J Clin Microbiol Infect Dis 2002; 21: 385.
18. Russell DL, Flood A, Zaroda TE, et al. Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients. Am J Transplant 2008; 8: 1737.
19. Hawkins C, Huang J, Jin N, et al. Persistent Staphylococcus aureus bacteremia: An analysis of risk factors and outcomes. Arch Intern Med 2007; 167: 1861.
20. Hamandi B, Holbrook AM, Humar A, et al. Delay of adequate empiric antibiotic therapy is associated with increased mortality among solid-organ transplant patients. Am J Transplant 2009; 9: 1657.
21. Jenkins TC, Price CS, Sabel AL, et al. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis 2008; 46: 1000.
22. Honda H, Krauss MJ, Jones JC, et al. The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med 2010; 123: 631.
23. Wiersinga WJ. Current insights in sepsis: From pathogenesis to new treatment targets. Curr Opin Crit Care 2011; 17: 480.
24. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309.
25. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America. Circulation 2005; 111: E394.
26. Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: A scientific statement from the American Heart Association. Circulation 2010; 121: 458.
27. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20: 250.